"These findings are very encouraging, suggesting that ReCET is a safe and feasible procedure that, when combined with ...

A new treatment combining ReCET and semaglutide could eliminate the need for insulin in type 2 diabetes, with 86% of ...

A new study out this week suggests that sticking to the diet could even help improve beta-cell function in people with type 2 ...

Groundbreaking research presented at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) that ...

The experimental therapy takes just a few weeks and removed insulin from the equation for 86% of trial participants.

Rachel Connor, Director of Research Partnerships at Breakthrough T1D, believes this pioneering study could “pave the way” for ...

Breakthrough stem cell transplants for diabetes have allowed patients to produce their own insulin, offering hope for a ...

The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...

The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer’s diagnosis in ...

Semaglutide, the active ingredient in Ozempic and Wegovy, appeared to reduce the risk of Alzheimer’s disease in people with ...

Research from earlier this week is the latest to suggest that semaglutide and other GLP-1 drugs can help treat people's ...